Logo image of XIN

XINYUAN REAL ESTATE CO L-ADR (XIN) Stock Fundamental Analysis

NYSE:XIN - New York Stock Exchange, Inc. - US98417P2048 - ADR - Currency: USD

2.75  +0.18 (+7%)

Fundamental Rating

1

Overall XIN gets a fundamental rating of 1 out of 10. We evaluated XIN against 65 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of XIN have multiple concerns. XIN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year XIN has reported negative net income.
XIN had a positive operating cash flow in the past year.
In the past 5 years XIN reported 4 times negative net income.
In multiple years XIN reported negative operating cash flow during the last 5 years.
XIN Yearly Net Income VS EBIT VS OCF VS FCFXIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.01%, XIN is in line with its industry, outperforming 55.38% of the companies in the same industry.
With a decent Return On Invested Capital value of 2.42%, XIN is doing good in the industry, outperforming 66.15% of the companies in the same industry.
Industry RankSector Rank
ROA -1.01%
ROE N/A
ROIC 2.42%
ROA(3y)-1.59%
ROA(5y)-2.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XIN Yearly ROA, ROE, ROICXIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

XIN's Operating Margin of 7.63% is fine compared to the rest of the industry. XIN outperforms 78.46% of its industry peers.
In the last couple of years the Operating Margin of XIN has declined.
XIN has a Gross Margin of 16.12%. This is in the lower half of the industry: XIN underperforms 61.54% of its industry peers.
XIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.63%
PM (TTM) N/A
GM 16.12%
OM growth 3YN/A
OM growth 5Y-9.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y53.91%
GM growth 5Y-6.51%
XIN Yearly Profit, Operating, Gross MarginsXIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so XIN is still creating some value.
Compared to 1 year ago, XIN has less shares outstanding
The number of shares outstanding for XIN has been increased compared to 5 years ago.
The debt/assets ratio for XIN has been reduced compared to a year ago.
XIN Yearly Shares OutstandingXIN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
XIN Yearly Total Debt VS Total AssetsXIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

XIN has an Altman-Z score of 0.10. This is a bad value and indicates that XIN is not financially healthy and even has some risk of bankruptcy.
XIN's Altman-Z score of 0.10 is on the low side compared to the rest of the industry. XIN is outperformed by 66.15% of its industry peers.
XIN has a debt to FCF ratio of 103.68. This is a negative value and a sign of low solvency as XIN would need 103.68 years to pay back of all of its debts.
XIN has a Debt to FCF ratio (103.68) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 103.68
Altman-Z 0.1
ROIC/WACC1.48
WACC1.64%
XIN Yearly LT Debt VS Equity VS FCFXIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

XIN has a Current Ratio of 1.12. This is a normal value and indicates that XIN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of XIN (1.12) is worse than 64.62% of its industry peers.
A Quick Ratio of 0.27 indicates that XIN may have some problems paying its short term obligations.
With a Quick ratio value of 0.27, XIN is not doing good in the industry: 89.23% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.27
XIN Yearly Current Assets VS Current LiabilitesXIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

0

3. Growth

3.1 Past

The earnings per share for XIN have decreased strongly by -215.38% in the last year.
The Revenue for XIN has decreased by -36.04% in the past year. This is quite bad
The Revenue for XIN have been decreasing by -26.99% on average. This is quite bad
EPS 1Y (TTM)-215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.33%
Revenue 1Y (TTM)-36.04%
Revenue growth 3Y-30.53%
Revenue growth 5Y-26.99%
Sales Q2Q%-13.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XIN Yearly Revenue VS EstimatesXIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XIN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XIN Price Earnings VS Forward Price EarningsXIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than XIN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.89
EV/EBITDA N/A
XIN Per share dataXIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XIN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XINYUAN REAL ESTATE CO L-ADR

NYSE:XIN (5/29/2025, 2:56:32 PM)

2.75

+0.18 (+7%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)12-13 2022-12-13/bmo
Inst Owners0.45%
Inst Owner Change14.13%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.44M
Analysts80
Price TargetN/A
Short Float %0.37%
Short Ratio0.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.03
Dividend Growth(5Y)-57.09%
DP-6.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 0.89
P/OCF 0.86
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.98
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.1
FCFY112.78%
OCF(TTM)3.21
OCFY116.6%
SpS91.74
BVpS-18.7
TBVpS-18.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.01%
ROE N/A
ROCE 3.22%
ROIC 2.42%
ROICexc 2.42%
ROICexgc 2.42%
OM 7.63%
PM (TTM) N/A
GM 16.12%
FCFM 3.38%
ROA(3y)-1.59%
ROA(5y)-2.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-26.22%
ROICexc growth 3YN/A
ROICexc growth 5Y-26.22%
OM growth 3YN/A
OM growth 5Y-9.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y53.91%
GM growth 5Y-6.51%
F-Score3
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 103.68
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.11%
Interest Coverage 1.03
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.27
Altman-Z 0.1
F-Score3
WACC1.64%
ROIC/WACC1.48
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.05%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-36.04%
Revenue growth 3Y-30.53%
Revenue growth 5Y-26.99%
Sales Q2Q%-13.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.4%
EBIT growth 3YN/A
EBIT growth 5Y-33.94%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y106.42%
FCF growth 3Y-49.29%
FCF growth 5Y-42.07%
OCF growth 1Y106.64%
OCF growth 3Y-48.99%
OCF growth 5Y-41.92%